慢性肾脏病的CMR评估及研究进展
CMR Evaluation and Research Progress of Chronic Kidney Disease
摘要: 慢性肾病(chronic kidney disease, CKD)患者早期虽然无明显临床症状，但是对心血管系统的损伤己经开始发挥作用，心肌纤维化是CKD进展的主要不良后果之一。本文就心脏磁共振成像(cardiac magnetic resonance, CMR)在CKD的心脏形态结构和功能、心肌应变及心肌组织特征评估方面的相关应用研究进展进行综述，旨在为早期发现CKD患者心肌损害及心功能障碍提供有价值的信息，为临床早期诊断及治疗提供影像学依据。
Abstract: Although patients with chronic kidney disease (CKD) have no obvious clinical symptoms in the early stage, the damage to the cardiovascular system has begun to play a role, and myocardial fibrosis is one of the main adverse consequences of the progress of CKD. This article reviews the progress in the application of cardiac magnetic resonance in the evaluation of cardiac morphology, structure and function, myocardial strain and myocardial tissue characteristics of CKD, in order to provide valuable information for early detection of myocardial damage and cardiac dysfunction in patients with CKD, and to provide imaging basis for early clinical diagnosis and treatment.
文章引用：王国辉, 孟莉. 慢性肾脏病的CMR评估及研究进展[J]. 临床医学进展, 2023, 13(7): 11707-11712. https://doi.org/10.12677/ACM.2023.1371640

参考文献

[1] (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 39, S1-S266.
[2] Hill, N.R., Fatoba, S.T., Oke, J.L., et al. (2016) Global Prev-alence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLOS ONE, 11, e0158765. [Google Scholar] [CrossRef] [PubMed]
[3] Matsushita, K., Van der Velde, M., Astor, B.C., et al. (2010) Association of Estimated Glomerular Filtration Rate and Albuminuria with All-Cause and Cardiovascular Mortality in General Population Cohorts: A Collaborative Meta-Analysis. The Lancet, 375, 2073-2081. [Google Scholar] [CrossRef] 
[4] Kis, E., Ablonczy, L. and Reusz György, S. (2018) Cardiac Magnetic Resonance Imaging of the Myocardium in Chronic Kidney Disease. Kidney and Blood Pressure Research, 43, 134-142. [Google Scholar] [CrossRef] [PubMed]
[5] Charytan, D.M., Padera, R., Helfand, A.M., et al. (2014) In-creased Concentration of Circulating Angiogenesis and Nitric Oxide Inhibitors Induces Endothelial to Mesenchymal Transition and Myocardial Fibrosis in Patients with Chronic Kidney Disease. International Journal of Cardiology, 176, 99-109. [Google Scholar] [CrossRef] [PubMed]
[6] Quarta, G., Gori, M., Iorio, A., et al. (2020) Cardiac Magnetic Resonance in Heart Failure with Preserved Ejection Fraction: Myocyte, Interstitium, Microvascular, and Meta-bolic Abnormalities. European Journal of Heart Failure, 22, 1065-1075. [Google Scholar] [CrossRef] [PubMed]
[7] Ibanez, B., Aletras, A.H., Arai, A.E., et al. (2019) Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel. JACC: Journal of the American College of Cardiology, 74, 238-256. [Google Scholar] [CrossRef] [PubMed]
[8] Badve, S.V., Palmer, S.C., Strippoli, G.F.M., et al. (2016) The Va-lidity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People with CKD: A Systematic Review and Meta-Analysis. American Journal of Kidney Diseases, 68, 554-563. [Google Scholar] [CrossRef] [PubMed]
[9] Smiseth, O.A., Torp, H., Opdahl, A., et al. (2016) Myocardial Strain Imaging: How Useful Is It in Clinical Decision Making? European Heart Journal, 37, 1196-1207. [Google Scholar] [CrossRef] [PubMed]
[10] Negishi, K., Negishi, T., Haluska, B.A., et al. (2014) Use of Speckle Strain to Assess Left Ventricular Responses to Cardiotoxic Chemotherapy and Cardioprotection. European Heart Jour-nal—Cardiovascular Imaging, 15, 324-331. [Google Scholar] [CrossRef] [PubMed]
[11] Scatteia, A., Baritussio, A. and Bucciarelli-Ducci, C. (2017) Strain Imaging Using Cardiac Magnetic Resonance. Heart Failure Reviews, 22, 465-476. [Google Scholar] [CrossRef] [PubMed]
[12] Truong, V.T., Palmer, C., Wolking, S., et al. (2020) Normal Left Atrial Strain and Strain Rate Using Cardiac Magnetic Resonance Feature Tracking in Healthy Volunteers. European Heart Journal—Cardiovascular Imaging, 21, 446-453. [Google Scholar] [CrossRef] [PubMed]
[13] Bucius, P., Erley, J., Tanacli, R., et al. (2020) Comparison of Feature Tracking, Fast-SENC, and Myocardial Tagging for Global and Segmental Left Ventricular Strain. ESC Heart Failure, 7, 523-532. [Google Scholar] [CrossRef] [PubMed]
[14] Flachskampf, F.A., Blankstein, R., Grayburn, P.A., et al. (2019) Global Longitudinal Shortening: A Positive Step towards Reducing Confusion Surrounding Global Longitudinal Strain. JACC: Cardiovascular Imaging, 12, 1566-1567. [Google Scholar] [CrossRef] [PubMed]
[15] Vo, H.Q., Marwick, T.H. and Negishi, K. (2018) MRI-Derived Myocardial Strain Measures in Normal Subjects. JACC: Cardiovascular Imaging, 11, 196-205. [Google Scholar] [CrossRef] [PubMed]
[16] Hoit, B.D. (2014) Left Atrial Size and Function: Role in Prognosis. JACC: Journal of the American College of Cardiology, 63, 493-505. [Google Scholar] [CrossRef] [PubMed]
[17] Kowallick, J.T., Morton, G., Lamata, P., et al. (2015) Quantification of Atrial Dynamics Using Cardiovascular Magnetic Resonance: Inter-Study Reproducibility. Journal of Cardiovascular Magnetic Resonance, 17, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[18] Krishnasamy, R., Isbel, N.M., Hawley, C.M., et al. (2015) Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease. PLOS ONE, 10, e0127044. [Google Scholar] [CrossRef] [PubMed]
[19] 周玉祥. 不同分期慢性肾病患者心肌Native T1-mapping和FT-CMR研究[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2020.
[20] Saeed, M., Van, T.A., Krug, R., et al. (2015) Cardiac MR Imaging: Current Status and Future Direction. Cardiovascular Diagnosis and Therapy, 5, 290-310.
[21] Rubenstein, J.C., Lee, D.C., Wu, E., et al. (2013) A Comparison of Cardiac Magnetic Resonance Imag-ing Peri-Infarct Border Zone Quantification Strategies for the Prediction of Ventricular Tachyarrhythmia Inducibility. Cardiology Journal, 20, 68-77. [Google Scholar] [CrossRef] 
[22] Karmonik, C., Malaty, A., Bikram, M., et al. (2014) Fast in Vivo Quantification of T1 and T2 MRI Relaxation Times in the Myocardium Based on Inversion Recovery SSFP with in Vitro Validation Post Gd-Based Contrast Administration. Cardiovascular Diagnosis and Ther-apy, 4, 88-96.
[23] Schmidt, A., Azevedo, C.F., Cheng, A., et al. (2007) Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients with Left Ventricular Dysfunction. Circulation, 115, 2006-2014. [Google Scholar] [CrossRef] 
[24] Mark, P.B., John-ston, N., et al. (2006) Redefinition of Uremic Cardiomyopathy by Contrast-Enhanced Cardiac Magnetic Resonance Im-aging. Kidney International, 69, 1839-1845. [Google Scholar] [CrossRef] [PubMed]
[25] Edwards, N.C., Ferro, C.J., Townend, J.N., et al. (2007) Myocardial Disease in Systemic Vasculitis and Autoimmune Disease Detected by Cardio-vascular Magnetic Resonance. Rheumatology (Oxford), 46, 1208-1209. [Google Scholar] [CrossRef] [PubMed]
[26] Hamlin, S.A., Henry, T.S., Little, B.P., et al. (2014) Mapping the Future of Cardiac MR Imaging: Case-Based Review of T1 and T2 Mapping Techniques. Radiographics, 34, 1594-1611. [Google Scholar] [CrossRef] [PubMed]
[27] Sibley, C.T., Noureldin, R.A., Gai, N., et al. (2012) T1 Mapping in Cardiomyopathy at Cardiac MR: Comparison with Endomyocardial Biopsy. Radiology, 265, 724-732. [Google Scholar] [CrossRef] [PubMed]
[28] Wong, T.C., Piehler, K., Meier, C.G., et al. (2012) Association be-tween Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality. Circulation, 126, 1206-1216. [Google Scholar] [CrossRef] 
[29] Appelbaum, E., Maron, B.J., Adabag, S., et al. (2012) Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy. Circulation: Cardiovascular Imaging, 5, 78-85. [Google Scholar] [CrossRef] 
[30] Moon, J.C., Messroghli, D.R., Kellman, P., et al. (2013) Myocardial T1 Mapping and Extracellular Volume Quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology Consensus Statement. Journal of Cardio-vascular Magnetic Resonance, 15, Article No. 92. [Google Scholar] [CrossRef] 
[31] Von Knobelsdorff-Brenkenhoff, F., Prothmann, M., Dieringer, M.A., et al. (2013) Myocardial T1 and T2 Mapping at 3 T: Reference Values, Influencing Factors and Implications. Journal of Cardiovascular Magnetic Resonance, 15, Article No. 53. [Google Scholar] [CrossRef] 
[32] Karamitsos, T.D., Piechnik, S.K., Banypersad, S.M., et al. (2013) Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis. JACC: Cardiovascular Imaging, 6, 488-497. [Google Scholar] [CrossRef] [PubMed]

为你推荐